New Hepatitis C Treatment: Solvadi/Sofosbuvir FDA Approved and Available Now

Great news for those with hepatitis C. Solvadi is available now for patients with hepatitis C. Sofosbuvir has now been approved by the FDA to treat hepatitis C. This video by Dr. Joseph Galati outlines the basic facts about hepatitis C, and a call to action to get tested and evaluated for treatment. With the approval of sofosbuvir, a wide range of hepatitis C patients can now be treated, including those with advanced hepatitis C and cirrhosis, as well as those awaiting liver transplant. Cures rates as high
Back to Top